Sirona Biochem Corp Stock Five Year Return
ZSB Stock | EUR 0.04 0.00 0.00% |
Fundamental analysis of Sirona Biochem allows traders to better anticipate movements in Sirona Biochem's stock price by examining its financial health and performance throughout various phases of its business cycle.
Sirona |
Sirona Biochem Corp Company Five Year Return Analysis
Sirona Biochem's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
According to the company disclosure, Sirona Biochem Corp has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all Germany stocks average (which is currently at 0.0).
Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
All Next | Launch Module |
Sirona Fundamentals
Return On Equity | -35.56 | |||
Return On Asset | -1.35 | |||
Operating Margin | (4.92) % | |||
Current Valuation | 23.24 M | |||
Shares Outstanding | 251.73 M | |||
Shares Owned By Insiders | 10.43 % | |||
Price To Earning | (6.67) X | |||
Price To Book | 33.90 X | |||
Price To Sales | 36.75 X | |||
Revenue | 268.02 K | |||
Gross Profit | 199.25 K | |||
EBITDA | (2.3 M) | |||
Net Income | (2.31 M) | |||
Cash And Equivalents | 120.26 K | |||
Total Debt | 468.77 K | |||
Debt To Equity | 470.90 % | |||
Current Ratio | 0.98 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (2.16 M) | |||
Earnings Per Share | (0.01) X | |||
Beta | -0.36 | |||
Market Capitalization | 17.51 M | |||
Total Asset | 1.29 M | |||
Z Score | 18.9 | |||
Net Asset | 1.29 M |
About Sirona Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
USOI | Credit Suisse X Links | |
ULTY | Tidal Trust II | |
CONY | YieldMax N Option | |
BCAT | BlackRock Capital Allocation | |
PDI | Pimco Dynamic Income |
Other Information on Investing in Sirona Stock
Sirona Biochem financial ratios help investors to determine whether Sirona Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.